Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 127

1.

Incorporating economic evaluation into immunization decision making in Canada: a workshop.

Langley JM, Krahn M, Husereau D, Spika J, Fisman DN, Chit A, Van Exan R.

Expert Rev Vaccines. 2014 Jul 23:1-6. [Epub ahead of print] No abstract available.

PMID:
25052459
[PubMed - as supplied by publisher]
Free Article
2.

Invasive candidiasis in low birth weight preterm infants: risk factors, clinical course and outcome in a prospective multicenter study of cases and their matched controls.

Barton M, O'Brien K, Robinson JL, Davies DH, Simpson K, Asztalos E, Langley JM, Le Saux N, Sauve R, Synnes A, Tan B, de Repentigny L, Rubin E, Hui C, Kovacs L, Richardson SE.

BMC Infect Dis. 2014 Jun 12;14:327. doi: 10.1186/1471-2334-14-327.

PMID:
24924877
[PubMed - in process]
Free PMC Article
3.

Comparison of the Safety and Immunogenicity of a Novel Quadrivalent Meningococcal ACWY-Tetanus Toxoid Conjugate Vaccine and a Marketed Quadrivalent Meningococcal ACWY-Diphtheria Toxoid Conjugate Vaccine in Healthy Individuals 10-25 Years of Age.

Halperin SA, Baine Y, Domachowske JB, Aggarwal N, Simon M, Langley JM, McNeil SA, Friedland LR, Bianco V, Baccarini CI, Miller JM.

J Pediatric Infect Dis Soc. 2014 Mar;3(1):33-42. Epub 2013 Oct 17.

PMID:
24567843
[PubMed]
4.

Respiratory syncytial virus-associated intensive care unit admission in children in Southern China.

Zhang Q, Guo Z, Langley JM, Bai Z.

BMC Res Notes. 2013 Nov 8;6:447. doi: 10.1186/1756-0500-6-447.

PMID:
24206961
[PubMed - in process]
Free PMC Article
5.

Severe combined immunodeficiency (SCID) in Canadian children: a national surveillance study.

Rozmus J, Junker A, Thibodeau ML, Grenier D, Turvey SE, Yacoub W, Embree J, Haddad E, Langley JM, Ramsingh RM, Singh VA, Long R, Schultz KR.

J Clin Immunol. 2013 Nov;33(8):1310-6.

PMID:
24122030
[PubMed - indexed for MEDLINE]
6.

Immunogenicity and safety of an inactivated quadrivalent influenza vaccine candidate: a phase III randomized controlled trial in children.

Langley JM, Carmona Martinez A, Chatterjee A, Halperin SA, McNeil S, Reisinger KS, Aggarwal N, Huang LM, Peng CT, Garcia-Sicilia J, Salamanca de la Cueva I, Cabañas F, Treviño-Garza C, Rodríguez-Weber MA, de la O M, Chandrasekaran V, Dewé W, Liu A, Innis BL, Jain VK.

J Infect Dis. 2013 Aug 15;208(4):544-53. doi: 10.1093/infdis/jit263. Epub 2013 Jul 11. Erratum in: J Infect Dis. 2014 May 1;209(9):1494.

PMID:
23847058
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Elevated inflammatory mediators in adults with oculorespiratory syndrome following influenza immunization: a public health agency of Canada/Canadian Institutes of Health Research Influenza Research Network Study.

Al-Dabbagh M, Lapphra K, Scheifele DW, Halperin SA, Langley JM, Cho P, Kollmann TR, Li Y, De Serres G, Fortuno ES 3rd, Bettinger JA.

Clin Vaccine Immunol. 2013 Aug;20(8):1108-14. doi: 10.1128/CVI.00659-12. Epub 2013 May 22.

PMID:
23697573
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial.

Dobson SR, McNeil S, Dionne M, Dawar M, Ogilvie G, Krajden M, Sauvageau C, Scheifele DW, Kollmann TR, Halperin SA, Langley JM, Bettinger JA, Singer J, Money D, Miller D, Naus M, Marra F, Young E.

JAMA. 2013 May 1;309(17):1793-802. doi: 10.1001/jama.2013.1625.

PMID:
23632723
[PubMed - indexed for MEDLINE]
9.

Immunogenicity of an investigational hepatitis B vaccine (hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide) in nonresponders to licensed hepatitis B vaccine.

Halperin SA, Ward BJ, Dionne M, Langley JM, McNeil SA, Smith B, Mackinnon-Cameron D, Heyward WL, Martin JT.

Hum Vaccin Immunother. 2013 Jul;9(7):1438-44. doi: 10.4161/hv.24256. Epub 2013 Apr 9.

PMID:
23571179
[PubMed - indexed for MEDLINE]
10.

Immunological priming induced by a two-dose series of H5N1 influenza antigen, administered alone or in combination with two different formulations of AS03 adjuvant in adults: Results of a randomised single heterologous booster dose study at 15 months.

Risi G, Frenette L, Langley JM, Li P, Riff D, Sheldon E, Vaughn DW, Fries L.

Vaccine. 2013 Jan 2;31(2):436-7. No abstract available.

PMID:
23387064
[PubMed - indexed for MEDLINE]
11.

Splenectomy: reducing the risk of infection.

Langley JM, McNeil S.

CMAJ. 2012 Nov 20;184(17):1926-7. doi: 10.1503/cmaj.112-2085. No abstract available.

PMID:
23166315
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

A randomized, controlled non-inferiority trial comparing A(H1N1)pmd09 vaccine antigen, with and without AS03 adjuvant system, co-administered or sequentially administered with an inactivated trivalent seasonal influenza vaccine.

Langley JM, Frenette L, Chu L, McNeil S, Halperin S, Li P, Vaughn D.

BMC Infect Dis. 2012 Oct 30;12:279. doi: 10.1186/1471-2334-12-279.

PMID:
23110320
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

A randomized control trial comparing immunogenicity, safety, and preference for self- versus nurse-administered intradermal influenza vaccine.

Coleman BL, McGeer AJ, Halperin SA, Langley JM, Shamout Y, Taddio A, Shah V, McNeil SA.

Vaccine. 2012 Sep 28;30(44):6287-93. doi: 10.1016/j.vaccine.2012.08.006. Epub 2012 Aug 16.

PMID:
22902784
[PubMed - indexed for MEDLINE]
14.

Randomized, multicenter trial of a single dose of AS03-adjuvanted or unadjuvanted H1N1 2009 pandemic influenza vaccine in children 6 months to <9 years of age: safety and immunogenicity.

Langley JM, Reich D, Aggarwal N, Connor D, Lebel MH, Gupta A, Garfield H, Li P, Madan A, Vaughn DW.

Pediatr Infect Dis J. 2012 Aug;31(8):848-58. doi: 10.1097/INF.0b013e31825e6cd6.

PMID:
22801094
[PubMed - indexed for MEDLINE]
15.

Safety and immunogenicity of different two-dose regimens of an investigational hepatitis B vaccine (hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide) in healthy young adults.

Halperin SA, McNeil S, Langley JM, Smith B, MacKinnon-Cameron D, McCall-Sani R, Heyward WL, Martin JT.

Vaccine. 2012 Aug 3;30(36):5445-8. doi: 10.1016/j.vaccine.2012.05.074. Epub 2012 Jun 13.

PMID:
22704926
[PubMed - indexed for MEDLINE]
16.

National surveillance of methicillin-resistant Staphylococcus aureus among hospitalized pediatric patients in Canadian acute care facilities, 1995-2007.

Matlow A, Forgie S, Pelude L, Embree J, Gravel D, Langley JM, Saux NL, Moore D, Mounchili A, Mulvey M, Shurgold J, Simor AE, Thomas E, Vayalumkal J; Canadian Nosocomial Infection Surveillance Program.

Pediatr Infect Dis J. 2012 Aug;31(8):814-20. doi: 10.1097/INF.0b013e31825c48a0.

PMID:
22565289
[PubMed - indexed for MEDLINE]
17.

Safety and immunogenicity of 2010-2011 H1N12009-containing trivalent inactivated influenza vaccine in children 12-59 months of age previously given AS03-adjuvanted H1N12009 pandemic vaccine: a PHAC/CIHR Influenza Research Network (PCIRN) study.

Langley JM, Scheifele DW, Quach C, Vanderkooi OG, Ward B, McNeil S, Dobson S, Kellner JD, Kuhn S, Kollman T, MacKinnon-Cameron D, Smith B, Li Y, Halperin SA.

Vaccine. 2012 May 14;30(23):3389-94. doi: 10.1016/j.vaccine.2012.03.046. Epub 2012 Mar 30.

PMID:
22469860
[PubMed - indexed for MEDLINE]
18.

Human challenge studies: a review of adequacy of reporting methods and results.

Kalil JA, Halperin SA, Langley JM.

Future Microbiol. 2012 Apr;7(4):481-95. doi: 10.2217/fmb.12.15. Review.

PMID:
22439725
[PubMed - indexed for MEDLINE]
19.

Persistence of the immune response at 5 years of age following infant immunisation with investigational quadrivalent MenACWY conjugate vaccine formulations.

Khatami A, Snape MD, Davis E, Layton H, John T, Yu LM, Dull PM, Gill CJ, Odrjlin T, Dobson S, Halperin SA, Langley JM, McNeil SA, Pollard AJ.

Vaccine. 2012 Apr 16;30(18):2831-8. doi: 10.1016/j.vaccine.2012.02.046. Epub 2012 Mar 3.

PMID:
22394992
[PubMed - indexed for MEDLINE]
20.

Immunogenicity and Safety of 2 Dose Levels of a Thimerosal-Free Trivalent Seasonal Influenza Vaccine in Children Aged 6-35 Months: A Randomized, Controlled Trial.

Langley JM, Vanderkooi OG, Garfield HA, Hebert J, Chandrasekaran V, Jain VK, Fries L.

J Pediatric Infect Dis Soc. 2012 Mar;1(1):55-63.

PMID:
23687572
[PubMed]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk